Recruiting PHASE4 INTERVENTIONAL 1-arm NCT06878482

Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease

Effect of Increasing Blood Flow by Botulinum Toxin Local Injection for Severe Peripheral Artery Occlusive Disease: Preliminary Report

Sponsor: Yonsei University

Conditions Blood Circulation Botulinum Toxins, Type A Chronic Ulcer of Lower Extremity Wound

Interventions Botulinum toxin A

Updated 2 times since 2025 Last updated: Mar 11, 2025 Started: Apr 17, 2023 Primary completion: Mar 31, 2026 Completion: Mar 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Blood Circulation and Botulinum Toxins, Type A, this trial is actively recruiting participants. The trial is conducted by Yonsei University and has accumulated 2 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE4
Apr 2025 — Sep 2025 [monthly]

Recruiting PHASE4

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yonsei University

Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yongin-si, South Korea